Complication, Foreign Body Granuloma, Surgery
Conditions
Keywords
disease-free, autoimmune/inflammatory syndrome induced by adjuvants (ASIA), adjuvant disease
Brief summary
Illicit subcutaneous injection of high-viscosity fluids for restoration and improvement of body contour is a growing trend all around the world. Many local and systemic complications have been described. Local complications include deformity at the site of injection, granulomas and several skin changes like erythema, induration, and plaques (well-circumscribed, elevated, superficial, solid lesion). The investigator designed a single-center, cross-sectional, retrospective, consecutive case series study and evaluated 49 surgeries performed in 35 patients with the history of foreign substances injection for cosmetic purposes and developed local complications. Investigators divided 4 groups accordingly to localization of foreign substances (FS). Group 1) FS disseminated to both lower extremities and buttocks; group 2) FS isolated to buttocks with moderate to severe skin changes, Group 3) FS isolated to lower legs with mild skin changes and superficial ulcerations and 4) FS isolated to lower legs with moderate to severe skin changes and/or ulceration. The investigators treated all patients surgically, which consisted of isolate ultrasonic liposuction for extraction of the material from the affected region (group 1) In-bloc excision and primary closure (group 2), Resection plus Vacuum assisted closure (VAC) and split thickness skin graft (STSG) (group 3) and In-bloc excision and microsurgical reconstruction (group 4). Statistical analysis was performed to find relations between type of surgery with complications, reactivation of symptoms, time for reactivation and a disease-free survival test (kaplan meier) was done.
Interventions
(group 1) In-bloc excision and primary closure (group 2), Resection plus Vacuum assisted closure (VAC) and split thickness skin graft (STSG) (group 3) and In-bloc excision and microsurgical reconstruction (group 4).
Sponsors
Study design
Eligibility
Inclusion criteria
* History of injection of foreign substances for cosmetic purposes * Develop symptoms of Autoimmune syndrome induced by adjuvants * Mild to severe skin changes
Exclusion criteria
* Refuse to participate in the analysis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Complications | 30 days | Describe if patients have or not postoperative complications |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Reactivation of symptoms | 9 to 76 months | Relapse of symptoms or new local complications |
| Time for reactivation of symptoms | 9 to 76 months | Account the number of months for reactivation of symptoms |
Countries
Mexico